PT1555267E - 2,3¿di-hidro-6-nitroimidazo[2,1-b]oxazoles - Google Patents

2,3¿di-hidro-6-nitroimidazo[2,1-b]oxazoles Download PDF

Info

Publication number: PT1555267E
Authority: PT; Portugal
Prior art keywords: nitroimidazo; oxazoles; dihydro
Prior art date: 2002-10-11

Application number

PT37540853T

Other languages

English (en)

Inventor

Hidetsugu Tsubouchi

Hirofumi Sasaki

Motohiro Itotani

Yoshikazu Haraguchi

Shin Miyamura

Makoto Matsumoto

Masanori Kawasaki

Takumi Sumida

Takeshi Hasegawa

Hideaki Kuroda

Takeshi Kuroda

Takayuki Matsuzaki

Kuninori Tai

Makoto Komatsu

Hiroyuki Hashizume

Tatsuo Tomishige

Yuji Seike

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-11

Filing date

2003-10-10

Publication date

2013-01-29

2003-10-10 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

2013-01-29 Publication of PT1555267E publication Critical patent/PT1555267E/pt

Links

QISRGAUYEHQMJV-UHFFFAOYSA-N 6-nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazole Chemical class C1COC2=NC([N+](=O)[O-])=CN21 QISRGAUYEHQMJV-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

PT37540853T 2002-10-11 2003-10-10 2,3¿di-hidro-6-nitroimidazo[2,1-b]oxazoles PT1555267E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2002298259		2002-10-11

Publications (1)

Publication Number	Publication Date
PT1555267E true PT1555267E (pt)	2013-01-29

Family

ID=32089299

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT37540853T PT1555267E (pt)	2002-10-11	2003-10-10	2,3¿di-hidro-6-nitroimidazo[2,1-b]oxazoles

Country Status (27)

Country	Link
US (1)	US7262212B2 (pt)
EP (2)	EP1555267B1 (pt)
JP (1)	JP4186065B2 (pt)
KR (1)	KR100723847B1 (pt)
CN (4)	CN102532162B (pt)
AR (4)	AR041198A1 (pt)
AU (1)	AU2003272979B2 (pt)
BE (1)	BE2014C053I2 (pt)
BR (1)	BRPI0314344B8 (pt)
CA (1)	CA2497569C (pt)
CY (2)	CY1113578T1 (pt)
DK (1)	DK1555267T3 (pt)
ES (1)	ES2400179T3 (pt)
FR (1)	FR14C0066I2 (pt)
HK (2)	HK1085463A1 (pt)
HU (1)	HUS1400046I1 (pt)
LU (1)	LU92517I2 (pt)
MX (1)	MXPA05003674A (pt)
MY (1)	MY139244A (pt)
PL (3)	PL404913A1 (pt)
PT (1)	PT1555267E (pt)
RU (1)	RU2326121C3 (pt)
SI (1)	SI1555267T1 (pt)
TW (1)	TWI347946B (pt)
UA (1)	UA83200C2 (pt)
WO (1)	WO2004033463A1 (pt)
ZA (1)	ZA200501033B (pt)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002036587A2 (en)	2000-11-01	2002-05-10	Cor Therapeutics, Inc.	Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides
WO2004035547A1 (ja)	2002-10-15	2004-04-29	Otsuka Pharmaceutical Co., Ltd.	１位置換―４―ニトロイミダゾール化合物及びその製造法
KR100851802B1 (ko) *	2003-10-31	2008-08-13	오쓰까 세이야꾸 가부시키가이샤	결핵의 치료를 위한2,3-디히드로-6-니트로이미다조[2,1-ｂ]옥사졸 화합물
JP4761756B2 (ja) *	2003-10-31	2011-08-31	大塚製薬株式会社	２，３−ジヒドロイミダゾ［２，１−ｂ］オキサゾ−ル化合物
TWI300409B (en)	2004-02-18	2008-09-01	Otsuka Pharma Co Ltd	Method for producing 4-nitroimidazole compound
WO2005095380A1 (ja)	2004-03-31	2005-10-13	Nippon Soda Co., Ltd.	環状アミン化合物および有害生物防除剤
JP4787529B2 (ja) *	2004-04-09	2011-10-05	大塚製薬株式会社	医薬組成物
JP4789966B2 (ja) *	2004-04-09	2011-10-12	大塚製薬株式会社	医薬組成物
WO2007002057A1 (en) *	2005-06-20	2007-01-04	Schering Corporation	Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
KR101294921B1 (ko) *	2005-07-28	2013-08-08	오츠카 세이야쿠 가부시키가이샤	2,3-디히드로-6-니트로이미다조〔2,1-ｂ〕옥사졸 유도체 함유 제약 조성물
TW201233389A (en) *	2005-10-05	2012-08-16	Otsuka Pharma Co Ltd	Antituberculous therapeutic drugs and kit containing the same
JP5105818B2 (ja) *	2005-10-05	2012-12-26	大塚製薬株式会社	医薬組成物
US8338607B2 (en)	2005-10-06	2012-12-25	Nippon Soda Co., Ltd.	Cyclic amine compounds and agents for pest control
TW200800268A (en) *	2005-11-04	2008-01-01	Otsuka Pharma Co Ltd	Medicinal composition showing improved drug absorbability
EP1968961A2 (en)	2005-12-21	2008-09-17	Decode Genetics EHF	Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
EP1986637A1 (en) *	2006-02-13	2008-11-05	Laboratoires Serono SA	Sulfonamide derivatives for the treatment of bacterial infections
JP2007297305A (ja) *	2006-04-28	2007-11-15	Daiso Co Ltd	Ｎ−（２，３−エポキシ−２−メチルプロピル）フタルイミドの製造法
EP2125750B1 (en) *	2007-02-26	2014-05-21	Vitae Pharmaceuticals, Inc.	Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AR070301A1 (es)	2007-05-08	2010-03-31	Otsuka Pharma Co Ltd	Compuesto epoxi y metodo para producir el mismo
EP2183228B1 (en) *	2007-07-26	2014-08-20	Vitae Pharmaceuticals, Inc.	CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1
CL2008002384A1 (es) *	2007-08-15	2009-07-17	Glaxo Group Ltd	Compuestos derivados de quinoliniloxipiperidina y pirrolidina, composicion farmaceutica, combinacion farmaceutica, util para el tratamiento de enfermedades inflamatorias y/o alergicas del tracto respiratorio.
JP2011500634A (ja) *	2007-10-16	2011-01-06	グラクソグループリミテッド	炎症性疾患およびアレルギー性疾患の治療に用いるキノリン誘導体
AR069207A1 (es) *	2007-11-07	2010-01-06	Vitae Pharmaceuticals Inc	Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
CA2708303A1 (en)	2007-12-11	2009-06-18	Vitae Pharmaceuticals, Inc.	Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW200934490A (en) *	2008-01-07	2009-08-16	Vitae Pharmaceuticals Inc	Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
CA2712500A1 (en)	2008-01-24	2009-07-30	Vitae Pharmaceuticals, Inc.	Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009102428A2 (en) *	2008-02-11	2009-08-20	Vitae Pharmaceuticals, Inc.	1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
EP2254872A2 (en) *	2008-02-15	2010-12-01	Vitae Pharmaceuticals, Inc.	Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
JP5538356B2 (ja) *	2008-03-18	2014-07-02	ヴァイティーファーマシューティカルズ，インコーポレイテッド	１１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤
AU2009228293B2 (en) *	2008-03-26	2012-11-08	Tennor Therapeutics (Suzhou) Limited	Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
EP2291370B1 (en)	2008-05-01	2013-11-27	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2722427A1 (en)	2008-05-01	2009-11-05	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5451752B2 (ja) *	2008-05-01	2014-03-26	ヴァイティーファーマシューティカルズ，インコーポレイテッド	１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
CA2723039A1 (en)	2008-05-01	2009-11-05	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2010010157A2 (en)	2008-07-25	2010-01-28	Boehringer Ingelheim International Gmbh	INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
AU2009274567B2 (en)	2008-07-25	2013-04-04	Boehringer Ingelheim International Gmbh	Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
CN102186833A (zh) *	2008-08-18	2011-09-14	耶鲁大学	Mif调节剂
US9540322B2 (en)	2008-08-18	2017-01-10	Yale University	MIF modulators
US9643922B2 (en)	2008-08-18	2017-05-09	Yale University	MIF modulators
US8558005B2 (en) *	2008-08-21	2013-10-15	Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik	Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof
WO2010143007A1 (en) *	2009-06-10	2010-12-16	Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik	Method for the production of 2-halogeno-4-nitroimidazole
CA2744946A1 (en)	2009-02-04	2010-08-12	Boehringer Ingelheim International Gmbh	Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW201039034A (en) *	2009-04-27	2010-11-01	Chunghwa Picture Tubes Ltd	Pixel structure and the method of forming the same
US20100331320A1 (en) *	2009-04-30	2010-12-30	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8680093B2 (en)	2009-04-30	2014-03-25	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2011011123A1 (en)	2009-06-11	2011-01-27	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
WO2011002910A1 (en)	2009-07-01	2011-01-06	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AU2010278777B2 (en) *	2009-07-31	2015-05-07	Global Alliance For Tb Drug Development	Nitroimidazooxazines and their uses in anti-tubercular therapy
ES2530266T3 (es) *	2009-07-31	2015-02-27	Global Alliance For Tb Drug Development	Análogos de nitroimidazooxazina y sus usos
US9198913B2 (en)	2009-07-31	2015-12-01	Global Alliance For Tb Drug Development	Nitroimidazooxazines and their uses in anti-tubercular therapy
JP5770096B2 (ja)	2009-10-26	2015-08-26	富士フイルムＲｉファーマ株式会社	感染症診断薬
TW201200523A (en)	2010-01-29	2012-01-01	Otsuka Pharma Co Ltd	Synthetic intermediate of oxazole compound and method for producing the same
GB201012209D0 (en) *	2010-05-31	2010-09-08	Ge Healthcare Ltd	In vivo imaging agent
US8933072B2 (en)	2010-06-16	2015-01-13	Vitae Pharmaceuticals, Inc.	Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
JP5813106B2 (ja)	2010-06-25	2015-11-17	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	代謝障害の処置のための１１−β−ＨＳＤ１のインヒビターとしてのアザスピロヘキサノン
EP2635268A1 (en)	2010-11-02	2013-09-11	Boehringer Ingelheim International GmbH	Pharmaceutical combinations for the treatment of metabolic disorders
EP2697232B1 (en)	2011-04-15	2016-05-18	Otsuka Pharmaceutical Co., Ltd.	6,7-dihydroimidazo[2,1-b][1,3]oxazine bactericides
JP2015006994A (ja) *	2011-10-28	2015-01-15	大正製薬株式会社	ジヒドロイミダゾオキサゾール誘導体
WO2014014845A1 (en)	2012-07-18	2014-01-23	Vertex Pharmaceuticals Incorporated	Combination therapy comprising\|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-\|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium\|diseases
FR3000064A1 (fr)	2012-12-21	2014-06-27	Univ Lille Ii Droit & Sante	Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
ES2707362T3 (es) *	2013-10-04	2019-04-03	Council Scient Ind Res	6-nitro-2,3-dihidroimidazo [2,1-b] oxazoles y un procedimiento de preparación de los mismos
CN103524492A (zh) *	2013-10-23	2014-01-22	中国药科大学	侧链含硝基咪唑基团取代的喹诺酮类化合物、其制备及用途
AR101704A1 (es)	2014-08-28	2017-01-04	Otsuka Pharma Co Ltd	Compuestos heterocíclicos fusionados
JP6467042B2 (ja) *	2014-10-21	2019-02-06	カウンシルオブサイエンティフィックアンドインダストリアルリサーチ	抗マイコバクテリア剤としての置換１，２，３−トリアゾール−１−イル−メチル−２，３−ジヒドロ−２−メチル−６−ニトロイミダゾ［２，１−ｂ］オキサゾールとその調製方法
CN105732659B (zh) *	2014-12-12	2019-07-16	上海阳帆医药科技有限公司	硝基咪唑类化合物及其制备方法和在制药中的用途
WO2016119706A1 (zh) *	2015-01-29	2016-08-04	南京明德新药研发股份有限公司	抗肺结核病的硝基咪唑衍生物
WO2016158737A1 (ja) *	2015-03-27	2016-10-06	大塚製薬株式会社	１－（４－ヒドロキシフェニル）－４－（４－トリフルオロメトキシフェノキシ）ピペリジン又はその塩の製造方法
CN106317072B (zh) *	2015-06-17	2020-03-17	盟科医药技术(上海)有限公司	用于分枝杆菌感染治疗的杂环化合物及其应用
CN108884044B (zh)	2016-02-26	2023-01-31	大塚制药株式会社	哌啶衍生物
CN105859628B (zh) *	2016-04-19	2018-08-07	清远职业技术学院	一种抗菌化合物对n咪唑苯甲醛缩邻甲苯胺希夫碱及其制备方法和应用
US20190276475A1 (en) *	2016-07-22	2019-09-12	Medshine Discovery Inc.	Crystal and salt of nitroimidazole, and manufacturing method thereof
SI3668879T1 (sl) *	2017-08-16	2022-04-29	Glaxosmithkline Intellectual Property Development Limited	Nove spojine
CN112236141A (zh)	2018-06-11	2021-01-15	大塚制药株式会社	包含德拉马尼的组合物
CN109705022A (zh) *	2018-12-28	2019-05-03	上海彩迩文生化科技有限公司	一种芳香胺中间体的制备方法
CN112300192B (zh) *	2019-08-02	2023-08-11	南京长澳医药科技有限公司	硝基咪唑类化合物及其制备方法和用途
CN110483549B (zh) *	2019-08-30	2021-03-05	沈阳药科大学	一种硝基咪唑吡喃类抗结核药物的制备方法
CN110615800A (zh) *	2019-10-16	2019-12-27	李丽丽	硝基咪唑类化合物及其制备方法和用途
CN112156088B (zh) *	2020-10-30	2021-08-31	健民药业集团股份有限公司	一种化合物在制备结核分枝杆菌抑制剂中的用途
CN113603706A (zh) *	2021-08-04	2021-11-05	深圳市泰力生物医药有限公司	德拉马尼的晶型、含有该晶型的活性药物和药物组合物
CN115368252B (zh) *	2022-09-19	2024-01-12	西北农林科技大学	一种4-胺基酚类衍生物及应用
CN116640106B (zh) *	2023-05-11	2024-03-08	郑州大学	一种苯基哌嗪类化合物及其制备方法、应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5668127A (en)	1995-06-26	1997-09-16	Pathogenesis Corporation	Nitroimidazole antibacterial compounds and methods of use thereof

2003
- 2003-10-09 TW TW092128165A patent/TWI347946B/zh not_active IP Right Cessation
- 2003-10-09 AR ARP030103673A patent/AR041198A1/es active IP Right Grant
- 2003-10-10 CA CA2497569A patent/CA2497569C/en not_active Expired - Lifetime
- 2003-10-10 PL PL404913A patent/PL404913A1/pl unknown
- 2003-10-10 ES ES03754085T patent/ES2400179T3/es not_active Expired - Lifetime
- 2003-10-10 MX MXPA05003674A patent/MXPA05003674A/es active IP Right Grant
- 2003-10-10 EP EP03754085A patent/EP1555267B1/en not_active Expired - Lifetime
- 2003-10-10 PL PL376157A patent/PL217919B1/pl unknown
- 2003-10-10 DK DK03754085.3T patent/DK1555267T3/da active
- 2003-10-10 KR KR1020057004567A patent/KR100723847B1/ko active Protection Beyond IP Right Term
- 2003-10-10 US US10/530,429 patent/US7262212B2/en not_active Expired - Lifetime
- 2003-10-10 CN CN201110416170.4A patent/CN102532162B/zh not_active Expired - Lifetime
- 2003-10-10 CN CNB2003801017508A patent/CN100366624C/zh not_active Expired - Lifetime
- 2003-10-10 MY MYPI20033866A patent/MY139244A/en unknown
- 2003-10-10 EP EP12193820.3A patent/EP2570418A3/en not_active Withdrawn
- 2003-10-10 PL PL409525A patent/PL409525A1/pl unknown
- 2003-10-10 UA UAA200504391A patent/UA83200C2/ru unknown
- 2003-10-10 CN CNA2007100040367A patent/CN101172981A/zh active Pending
- 2003-10-10 SI SI200332254T patent/SI1555267T1/sl unknown
- 2003-10-10 AU AU2003272979A patent/AU2003272979B2/en not_active Expired
- 2003-10-10 PT PT37540853T patent/PT1555267E/pt unknown
- 2003-10-10 BR BRPI0314344A patent/BRPI0314344B8/pt active IP Right Grant
- 2003-10-10 RU RU2005114017A patent/RU2326121C3/ru active Protection Beyond IP Right Term
- 2003-10-10 CN CNA2007100040371A patent/CN101255170A/zh active Pending
- 2003-10-10 WO PCT/JP2003/013070 patent/WO2004033463A1/ja active Application Filing
- 2003-10-14 JP JP2003353868A patent/JP4186065B2/ja not_active Expired - Lifetime
2005
- 2005-02-03 ZA ZA200501033A patent/ZA200501033B/en unknown
2006
- 2006-02-03 HK HK06101486A patent/HK1085463A1/xx not_active IP Right Cessation
2012
- 2012-04-23 AR ARP120101394A patent/AR086485A2/es unknown
- 2012-11-21 HK HK12111863.7A patent/HK1171018A1/xx not_active IP Right Cessation
2013
- 2013-01-25 CY CY20131100076T patent/CY1113578T1/el unknown
- 2013-02-08 AR ARP130100408A patent/AR089950A2/es unknown
- 2013-07-15 AR ARP130102514 patent/AR091771A2/es not_active Application Discontinuation
2014
- 2014-08-13 LU LU92517C patent/LU92517I2/xx unknown
- 2014-08-14 HU HUS1400046C patent/HUS1400046I1/hu unknown
- 2014-09-09 BE BE2014C053C patent/BE2014C053I2/fr unknown
- 2014-09-11 FR FR14C0066C patent/FR14C0066I2/fr active Active
- 2014-09-24 CY CY2014041C patent/CY2014041I2/el unknown

Also Published As

Publication number	Publication date
JP4186065B2 (ja)	2008-11-26
CY1113578T1 (el)	2016-06-22
EP1555267B1 (en)	2013-01-16
BE2014C053I2 (pt)	2022-08-30
BRPI0314344B8 (pt)	2021-05-25
PL376157A1 (en)	2005-12-27
FR14C0066I2 (fr)	2015-05-22
MXPA05003674A (es)	2005-06-08
KR20050061473A (ko)	2005-06-22
DK1555267T3 (da)	2013-02-11
HK1085463A1 (en)	2006-08-25
AU2003272979A1 (en)	2004-05-04
CY2014041I1 (el)	2016-07-27
UA83200C2 (en)	2008-06-25
AR091771A2 (es)	2015-02-25
CN1705670A (zh)	2005-12-07
PL404913A1 (pl)	2013-09-30
EP1555267A4 (en)	2010-08-18
AR041198A1 (es)	2005-05-04
CN101172981A (zh)	2008-05-07
AU2003272979B2 (en)	2009-07-23
US20060094767A1 (en)	2006-05-04
AR086485A2 (es)	2013-12-18
HUS1400046I1 (hu)	2017-04-28
US7262212B2 (en)	2007-08-28
RU2326121C3 (ru)	2021-09-17
HK1171018A1 (en)	2013-03-15
TWI347946B (en)	2011-09-01
TW200420568A (en)	2004-10-16
PL217919B1 (pl)	2014-09-30
JP2004149527A (ja)	2004-05-27
EP2570418A3 (en)	2013-07-03
PL409525A1 (pl)	2014-11-10
CA2497569C (en)	2011-05-24
LU92517I2 (fr)	2014-10-13
FR14C0066I1 (pt)	2014-10-17
WO2004033463A1 (ja)	2004-04-22
RU2005114017A (ru)	2006-01-20
RU2326121C2 (ru)	2008-06-10
CN100366624C (zh)	2008-02-06
CN102532162B (zh)	2015-05-27
CA2497569A1 (en)	2004-04-22
BRPI0314344B1 (pt)	2019-11-26
AR089950A2 (es)	2014-10-01
KR100723847B1 (ko)	2007-05-31
ZA200501033B (en)	2006-06-28
ES2400179T3 (es)	2013-04-08
MY139244A (en)	2009-09-30
BR0314344A (pt)	2005-07-12
CY2014041I2 (el)	2016-07-27
EP2570418A2 (en)	2013-03-20
CN101255170A (zh)	2008-09-03
CN102532162A (zh)	2012-07-04
EP1555267A1 (en)	2005-07-20
SI1555267T1 (sl)	2013-05-31

Publication	Publication Date	Title
HUS1400046I1 (hu)	2017-04-28	2,3-Dihidro-6-nitroimidazol[2,1-b]oxazol-származékok
DE60302150D1 (en)	2005-12-08	N-substituiete heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trion metalloproteinase inhibitoren
HK1078568A1 (en)	2006-03-17	2-(2,6-dichlorophenyl)-diarylimidazoles
HK1090368A1 (en)	2006-12-22	2,3,6-trisubstituted-4-pyrimidone derivatives
EP1542699A4 (en)	2009-03-25	COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
EP1617807A4 (en)	2007-02-21	SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
AU2003294726A1 (en)	2004-06-18	Window-winding arrangement
AU2003299648A1 (en)	2004-06-30	Substituted 4-phenyl-(1,3)-dioxanes
AU2003252722A1 (en)	2004-02-16	Toothbrush
AU2003235239A1 (en)	2003-11-17	Clothing having figure adjusting function
AU2003292420A1 (en)	2004-07-14	Antibacterial oxazolidinones
AU2003206406A1 (en)	2003-07-30	Textile
AU2003202606A1 (en)	2003-09-02	Tub arrangement
AU2002349632A1 (en)	2004-06-18	Flocking machine
AU2003297469A1 (en)	2004-07-22	Twin-headed toothbrush
AU2002258241A1 (en)	2003-12-12	Toothbrush
AU2003243065A1 (en)	2003-12-02	Grin-lens arrangement
PL375563A1 (en)	2005-11-28	Dibenzoxazepine
GB0218515D0 (en)	2002-09-18	S.d.s.
TJ20020735A (en)	2002-10-06	2-bROM-7-METHIL-5-OXO-5H-1,3,4-thyodyazol Ä3,2-AÜ pyrimidin
AU2002950249A0 (en)	2002-09-12	Improved sock
SI1549647T1 (sl)	2006-10-31	Substituirani C-imidazo(1,2-a)piridin-3-il-metilamini
AUPS288102A0 (en)	2002-06-27	Modified clothing
AUPS269202A0 (en)	2002-06-20	Scrummaging machine
AU2002951306A0 (en)	2002-09-26	Ball machine